tbuckley/cabot-search huggingface dataset:
Language barriers in medicine in the United States
Authors: S. Woloshin
Journal: JAMA (1995)

What the scalpel is to the surgeon, words are to the clinician... the conversation between doctor and patient is the heart of the practice of medicine.<sup>1</sup> The physician-patient relationship is built through communication and the effective use of language. Along with clinical reasoning, observations, and nonverbal cues, skillful use of language endows the history with its clinical power and establishes the medical interview as the clinician's most powerful tool.<sup>2-5</sup>Language is the means by which a physician accesses a patient's beliefs about health and illness,<sup>6</sup>creating an opportunity to address and reconcile different belief systems. Furthermore, it is through language that physicians and patients achieve an empathic connection that may be therapeutic in itself.<sup>7</sup> Because of language barriers, millions of US residents cannot have this connection with their physician. According to the 1990 US Census,<sup>8</sup>almost 14 million people living in the United States do
US Government criticized for helping to export a deadly epidemic of tobacco addiction
Authors: A. A. Skolnick
Journal: JAMA (1992)

MEMBERS of the Asia-Pacific Association for the Control of Tobacco (APACT) are calling on President George Bush "to stop dumping cigarettes on Asian nations." At a recent Eighth World Conference on Tobacco OR Health press conference in Buenos Aires, Argentina, representatives of APACT strongly protested what they say is an invasion of their countries by US tobacco companies that is aimed at Asian women and children. The association, which was organized in 1989 by antitobacco forces in China, Bangladesh, Hong Kong, Japan, Korea, Philippines, Malaysia, Thailand, Indonesia, Taiwan, and other countries of Asia, says it is angry over what it calls strong-arm tactics used by the US government to prevent their nations from adopting tobacco-control policies. "I know the United States needs to expand foreign markets to increase foreign trade," says APACT's honorary-life-president, David Yen, JD, of Taiwan. "Taiwan welcomes the importation of US goods, automobiles, airplanes, trains, and ships.
Highlights
Authors: Benjamin Greenberg
Journal: JAMA Neurology (2016)

Munger et al examine whether serum 25-hydroxyvitamin D (25[OH]D) levels in early pregnancy are associated with risk of multiple sclerosis (MS) in off spring.Maternal serum 25(OH)D levels were measured using a chemiluminescence assay.The risk of MS among off spring and association with maternal 25(OH)D levels were the main outcomes.They fi nd that insuffi cient maternal 25(OH)D during pregnancy may increase the risk of MS in off spring.
Risk factors associated to NAFLD-related advanced fibrosis in patients with normal ALT levels
Authors: Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, Javier Crespo, José Luis Calleja Panero, Carmelo García-Monzón, Judith Gómez-Camarero, Juan Caballería, Oreste Lo Iacono, Rafael Bañares, Francisco Javier Garcia-Samaniego Rey, Agustin Albillos, Rubén Francés, Conrado Fernández-Rodríguez, Moises Diago, German Soriano, Raul J. Andrade, Raquel Latorre Martínez, Francisco Jorquera, Rosa Ma Morillas, Desamparados Escudero-García, Pamela Estevez, Manuel Hernandez-Guerra, Salvador Augustin, Helena Pastor, Jesus M. Banales, Patricia Aspichueta, Salvador Benlloch, Jose Miguel Rosales Zabal, Javier Salmerón, Juan Turnés, Manuel Romero Gomez
Journal: Journal of Hepatology (2020)
Respiratory stimulation.
Authors: M C Pain
Journal: BMJ (1972)

The men concerned had received multiple injections of analgesics and antihistamines with consequent haematoma formation in the gluteal and lateral thigh musculature.With the exception of small volume injections during immunization, intramuscular therapy is usually unnecessary and always dangerous in patients with coagulation de- fects.The consequent haemorrhage not only causes pain and pressure on surrounding tissues, but may result in muscle fibrosis and permanent crippling.-I am, etc.,
Toxic Beryllium and Genetic Testing
Authors: Jim Danneskiold
Journal: Environmental Health Perspectives (2001)

LetterOpen AccessToxic beryllium and genetic testing.is companion ofToxic beryllium: new solutions for a chronic problem. J Danneskiold J Danneskiold Search for more papers by this author Published:1 May 2001https://doi.org/10.1289/ehp.109-a200bAboutSectionsPDF ToolsDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InReddit "Toxic beryllium and genetic testing.." Environmental Health Perspectives, 109(5), p. A200FiguresReferencesRelatedDetailsRelated articlesToxic beryllium: new solutions for a chronic problem.1 February 2001Environmental Health Perspectives Vol. 109, No. 5 May 2001Metrics About Article Metrics Publication History Originally published1 May 2001Published in print1 May 2001 Financial disclosuresPDF download License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days.
Les résultats des résections endoscopiques des adénomes ampullaires avec extension duodénale et des adénomes ampullaires conventionnels sont équivalents
Journal: Endoscopy (2018)

Cette équipe australienne a mené une étude rétrospective comparant les résultats des résections des adénomes ampullaires (AA) limités à l’ampoule et les lésions adénomateuses larges (LSL-A), définies par une plage adénomateuse dépassant le massif ampullaire et mesurant plus de 10 mm.
WEDNESDAY 21ST SEPTEMBER
Authors: S Vyas', R Owen2, P Hawtin', Mjp Arthur, D Jones, T Yapp, Gao Thomas, H Pylori, Serodiagnosis Pnair, J Stephens, E Mackay, K West, I Mayberry, Acb Wicks, B Rathbone, Serology Jel, M Mendall, S Khulusi, R Lloyd, N Molineaux, J Levy, Gastritis Pylori, Reflux Duodenogastric, J Katsogridakis, I Drake, D Warland, S Schorah, A Axon, L Malamou, ' Sa, Raptis Gastro
Journal: Gut (1994)

Recent reports of H. pylon survival in faeces and the mouth suggest the possibility of enteral transmission while sero- epidemiological studies have highlighted the importance of childhood in acquiring this chronic infection.Although the severity of disease may depend on differences in host susceptibility, the proposal for a single ulcerogenic strain is contentious.We investigated a three generation family for H. pylor strain heterogeneity, intrafamilial clustering and endoscopic abnormality.Upper gastrointestinal symptoms and treatment were recorded.Infection was determined by '3C-urea breath test and serology (ELISA:acid-extracted antigen:NCTC11638).All positive individuals consented to endoscopy and antral biopsies for culture and histology.Strains were characterized using RFLP of HaeIII restriction digests of the PCR products of urease A and B genes recovered from each individual and immunoblotting for the cagA product which is closely associated to duodenal ulceration.Of twenty-three subjects screened, 13 were seropositive of whom 11 were confirmed by "C-urea breath test.Endoscopy in these 11 subjects revealed duodenal ulceration in 7 with co-existing oesophagitis and gastric ulceration in one.One had gastric ulceration alone and another had severe oesophagitis alone.Genotypic analysis revealed clustering amongst first degree relatives.Active duodenal ulceration was not strain specific but all subjects with duodenal ulceration demonstrated immunoreactivity to the putative cagA product.These results identify clustering of H. pylon strains amongst first degree relatives.Furthermore the presence of duodenal ulceration with genotypically heterogenous strains associated with the cagA product suggests a possible pathogenic role for this protein.Finally, this study repudiates the proposal for a single ulcerogenic strain as defined by PCR-RFLP.W2
International Quality
Authors: Rebecca Voelker
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Families' self-interest and the cadaver's organs. What price consent?
Authors: E. D. Pellegrino
Journal: JAMA (1991)

IT IS TRAGIC for an eligible recipient to die for want of a lifesaving organ. The profession and society are under a clear moral compulsion to seek ways to prevent such deaths. But it would be equally tragic, even in order to save lives, to resort to such a morally dubious and destructive policy to increase the supply of donated organs as Peters suggests. His proposal that a $1000 death "benefit" be offered to motivate families to consent to removal of organs from their deceased relatives is logically, ethically, and practically flawed. In his sincere and understandable commitment to save lives, Peters follows an oversimplified line of reasoning: people die waiting for organ transplants. Organs are scarce because we have relied on altruism to motivate donors. Therefore, self-interest must replace altruism as a motive. With the obstacle of activism out of the way, Peters believes that an adequate supply, and
Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)
Authors: E. Van Cutsem, Y. Kang, H. Chung, L. Shen, A. Sawaki, F. Lordick, J. Hill, M. Lehle, A. Feyereislova, Y. Bang
Journal: Journal of Clinical Oncology (2009)

LBA4509 Background: Advanced GC is an incurable disease; new and less toxic treatments are needed. HER2 overexpression has been reported in 6–35% of stomach and gastroesophageal tumors. Trastuzumab (H; Herceptin), a monoclonal antibody against HER2, has shown survival benefits when given with CT in patients (pts) with HER2-positive early and metastatic breast cancer. The ToGA study is the first randomized, prospective, multicenter, phase III trial to study the efficacy and safety of H in HER2- positive GC. Methods: Pts with HER2-positive gastroesophageal and gastric adenocarcinoma (locally advanced, recurrent, or metastatic) were randomized to receive H+CT (5-fluorouracil or capecitabine and cisplatin) q3w for 6 cycles or CT alone. H was given until disease progression. The primary end point was overall survival (OS); secondary end points included overall response rate (ORR), progression-free survival, time to progression, duration of response, and safety. An interim analysis was planned at 75% of deaths and the Independent Data Monitoring Committee recommended releasing the data as the pre-specified boundary was exceeded and median follow-up of pts was 17.1 months. Results: Tumors from 3,807 pts were centrally tested for HER2 status: 22.1% were HER2 positive (abstract #4556). 594 pts were randomized 1:1 at sites in Europe, Latin America, and Asia. Baseline characteristics were well balanced across arms. Median OS was significantly improved with H+CT compared to CT alone: 13.5 vs. 11.1 months, respectively (p=0.0048; HR 0.74; 95% CI 0.60, 0.91). ORR was 47.3% in the H+CT arm and 34.5% in the CT arm (p=0.0017). Safety profiles were similar with no unexpected adverse events in the H+CT arm. There was no difference in symptomatic congestive heart failure between arms. Asymptomatic left ventricular ejection fraction decreases were reported in 4.6% of pts in the H+CT arm and 1.1% in the CT arm. Conclusions: This first randomized trial investigating anti-HER2 therapy in advanced GC showed that H+CT is superior to CT alone. The OS benefit indicates that H is a new, effective, and well-tolerated treatment for HER2-positive GC. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Hoffman-La Roche, Roche Products Pty Ltd Roche Hoffman-La Roche, Roche Hoffman-La Roche, Roche Hoffman-La Roche, Roche
Correction
Journal: BMJ (1928)

that a metabolic dlisturbance is tho cauise of the common cold, with Dr. E. WV.Goodall's paper on the epidemiic constitution, read before the Sectioni of Epidemiology and(l State Medicine of the Royal Society of Medicine, of which a full abstract was ptub- lished in ouir issuie of Novembier 5th, 1927 (p. 830).Dr. Chalmilers agrees thiat suchi a metabolic disturbaice exists, anid refers to his letter (JouItNAL, March 13thi, 1926, ).507), in which he coufirmed previouis observations oIn the -appearanice in the urine in such catarrhal con(litions of leLicini crystals, the exact nature of which has not yet beeni established..He does not believe, however, that a mild acidosis is lnecessarily present, althotugh marked aeetolne reactions have freqtucuitly beeni observed in con- currenit cases, bordering oni alkalosis, said to be dlue to an "inward.chtill."Investigations for somiie seven years have brought himi to the conclusioin that there is a definite disordered intestinal hepatic metabolism, leadinig to a disturbedi blood state, of which the altered calcium meta- bolism forms au importanit part.This predisposes to, if it does inot iniitiate, a diseased state of the body, of which the commoni cold is only one miauifestatioin.Exaniinationi of maniy samples of urinie duirinig the catarrhal seasonl resuilts frequenltly in the finding of inldicani, bile, oxalates, anid the leucin crystals.Dr. Chalml-ers fintds evidenice of this distuirbed metabolism-also in such concuirrent coniditions as the al burninutria of pregnianicy, eclampsia, uraemic conivulsionis, acuite eczema, and pyelitis, as well as in otlier cotnditions traceable, inIhis opiinioni, therefore, to what lie terms an " epidlemic constitution."TREATMENT OF VULVITIS.DR.LEO SPIRA (London) writes: Vulvitis appears to be one of the
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride
Authors: J. R. Mitchell
Journal: JAMA (1967)

In five studies, the antihypertensive effect of guanethidine sulfate was significantly reversed by two antidepressants, desipramine hydrochloride and protriptyline hydrochloride. This reversal was not immediate, requiring many hours before maximum antagonism was seen. After discontinuation of desipramine, an average of five days was required for the antihypertensive action of guanethidine to reappear. Three similar studies demonstrated that the antihypertensive action of bethanidine sulfate, a guanethidine-related drug, was reversed by desipramine also. The reversal of bethanidine was more rapid than with guanethidine, with almost maximum antagonism appearing within four hours, while the delay in the reappearance of bethanidine's antihypertensive action was similar to that seen with guanethidine. A blockade by the antidepressants of the uptake of the antihypertensives to their active site within the sympathetic neuron is suggested as a mechanism for the antagonism.
PRESERVATIVES AND PRESS AGENTS
Journal: JAMA (2010)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction
Journal: BMJ (1958)

Any Questions ?We publish below a selection of those questions and answers which seem of general interest.It is regretted that it is not possible to supply answers to all questions submitted.Age and Severity of Poliomyelitis Q.-Is poliomyelitis infection likely to be "more harm- less" in infants and young children than in older children and adults?A.-The outcome of an infection by the virus depends upon the pre-existence of antibodies in the serum which will prevent viraemia and involvement of the C.N.S. and also on the susceptibility of the neurones to attack.The levels of antibodies in the serum increase rapidly in early childhood, except when exposure to the virus has been prevented by good sanitation.Nevertheless, even in civilized communities most children of school age possess antibodies, so that the likelihood of poliomyelitis infection involving the C.N.S. diminishes steadily with age.The mortality rate from paralytic disease increases, however, with age, probably because adult neurones are more readily damaged than are those of infants or children.Serious residual effects or death are therefore more often seen when the paralytic disease occurs in an older child or an adult.In this sense therefore polio is more harmless in the young infant than in the older child or adult.Prednisolone for Infantile Eczema Q.-Is there any risk in using oral prednisolone in the
Epidemic hepatitis in a clinical laboratory. Possible association with computer card handling
Authors: C. P. Pattison
Journal: JAMA (1974)

During a six-month period (Dec 15, 1972, to June 15, 1973), hepatitis developed in five employees of a large, hospital-based clinical laboratory. Three employees had transient hepatitis B surface antigen (HB<sub>s</sub>Ag), one had antibody to surface antigen (anti-HB<sub>s</sub>), and one had neither. In the two years preceding this outbreak, only one laboratory employee had had overt hepatitis. Risk-factor analysis for ill employees and a control group of HB<sub>s</sub>Ag- and anti-HB<sub>s</sub>-negative laboratory employees matched for age, length of employment, and amount of exposure to blood specimens showed that only a history of sustaining cuts while handling laboratory requisitions was statisticallysignificant (<i>P</i>&lt;.005). Recognition of the possible cause of the outbreak and adoption of problem-oriented preventive measures have been associated with no further clinical cases of hepatitis in the past year. (<i>JAMA</i>230:854-857, 1974)
Orvosi Hetilap, Budapest
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Disaster prevention should be equal
Authors: None The Lancet Global Health
Journal: The Lancet Global Health (2017)

If you are feeling overwhelmed by Mother Nature's recent demonstrations of power, the current disaster map on reliefweb will not reassure you. It confirms at a glance the omnipresence and persistence of natural disasters: events such as havoc-wreaking monsoon rains in South Asia, flashfloods and landslides in Africa, powerful hurricanes and earthquakes in the Americas, sadly not unusual phenomena but particularly startling in their intensity this year, have upended the lives of hundreds of thousands of people since the beginning of 2017.
VITAMIN WITTICISMS
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal